Børge Sørvoll
Förmögenhet: 203 992 $ per 2026-06-30
Förmögenhet: 203 992 $ per 2026-06-30
Børge Sørvoll currently works at Biotec BetaGlucans AS, as Chairman and ArcticZymes Technologies ASA, as Chief Financial Officer from 2014.
Mr. Sørvoll also formerly worked at Troms Kraft Invest AS, as Managing Director & Chief Financial Officer, Front Exploration AS, as Chief Financial Officer, and Subsea 7 Norway AS, as Manager.
Mr. Sørvoll received his undergraduate degree from the University of Wyoming.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2024-12-31 | 100 428 ( 0,2 % ) | 203 992 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Finansdirektör/CFO | 2014-10-01 |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Ordförande | - |
| Företag | Position | Slut |
|---|---|---|
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Finansdirektör/CFO | - |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Företagsledare/Principal | - |
Troms Kraft Invest AS | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
University of Wyoming
University of Wyoming Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ArcticZymes Technologies ASA
ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
Front Exploration AS
Front Exploration AS Contract DrillingIndustrial Services Explores oil and gas | Industrial Services |
Subsea 7 Norway AS
Subsea 7 Norway AS Miscellaneous Commercial ServicesCommercial Services Engages in general trading activities | Commercial Services |
Troms Kraft Invest AS | |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån